Compare Nokia Corp (NOK) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs Revvity Inc — how do they compare? Nokia Corp trades at $10.73 (market cap $59.77B), while Revvity Inc trades at $124.14 (market cap $14.18B). The key difference: Nokia Corp is far larger — about 4.2× Revvity Inc's market cap, and Nokia Corp pays the higher dividend (1.53%). Which is the better fit depends on your goals.
| NOK | RVTY | |
|---|---|---|
Market Cap | $59.77B | $14.18B |
Sector | Technology | Technology |
52-Week High | $16.83 | $130.94 |
52-Week Low | $4.51 | $82.26 |
Enterprise Value | $57.71B | $16.50B |
Dividend Yield | 1.53% | 0.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nokia (NOK) trades at $10.66, up 6.18% on the day, supported by a bullish technical signal and positive momentum from AI-driven network infrastructure growth. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026, with revenue stabilizing around $20 billion annually. Analyst sentiment is predominantly bullish, with 61.5% recommending Buy, amid news of its return to the Euro Stoxx 50 index and expansion in Saudi AI research.
The outlook is cautiously optimistic, driven by AI and cloud demand, but risks include competitive pressures, volatile cash flow, and high valuation multiples. Investment opportunity hinges on execution of growth initiatives, while shareholders face exposure to telecom sector volatility and margin challenges.
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
